Differentiated model drives leadership in Reproductive Medicine


The acronyms IVI and RMA represent the two best assisted reproduction groups in Europe and the U.S., respectively. Together, they have since the beginning of the nineties been setting the standard in the field of reproduction, until in February 2017 they decided to merge to form the largest Reproductive Medicine group in the world. The same philosophy, the same practices and the same spirit of leadership led them to join forces to create IVIRMA Global, the world’s premier fertility group that leads the industry in research, success rates and patient care. From clinical excellence, to research and innovation, to teaching the next generation of reproductive endocrinologists, to advancing cutting edge protocols, standards and practices in the field, IVIRMA Global is not only synonymous with the most advanced clinics and treatments, it represents a bright new path for this emerging field of medicine: one of relentless commitment to discovery, progress and parenthood for everyone that desires it.

Developing this overarching commitment to Reproductive Medicine is possible through four key areas:

Medical Affairs

Ensuring medical excellence, maintaining leadership in assisted reproduction treatments and continuing to set the global standard in the field.


Pioneering scientific research in the field with more than 500 researchers and 3,800+ published papers (2x more than the rest of the industry combined)

Qui minus ab fugit recusandae. Deleniti non omnis quisquam.


Supplying all our clinics with the tools they need to succeed, and carrying out a meticulous inventory and assessment of internal processes to ensure top performance inside and outside the exam room.



The industry’s most trusted training programs to develop current and future staff, and the next generation of top reproductive endocrinologists and referring OBGYNs.